Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC6 | Q9UBN7 | 15/20 | 0.53 |
| ▸ | HDAC1 | Q13547 | 9/20 | 0.53 |
| ▸ | HDAC5 | Q9UQL6 | 4/20 | 0.53 |
| ▸ | HDAC4 | P56524 | 9/20 | 0.49 |
| ▸ | MKNK1 | Q9BUB5 | 1/20 | 0.49 |
| ▸ | MKNK2 | Q9HBH9 | 1/20 | 0.49 |
| ▸ | HDAC8 | Q9BY41 | 5/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29242083 | 0.84 | HDAC4 (0.47) | HDAC6HDAC1HDAC5HDAC4HDAC8 | |
| SCHEMBL29712264 | 0.83 | HDAC1 (0.65) | HDAC6HDAC1HDAC5HDAC4HDAC8 | |
| SCHEMBL19384961 | 0.83 | HDAC1 (0.65) | HDAC6HDAC1HDAC5HDAC4HDAC8 | |
| SCHEMBL28506637 | 0.82 | HDAC1 (0.48) | HDAC6HDAC1HDAC5HDAC8 | |
| SCHEMBL21903401 | 0.78 | HDAC6 (0.52) | HDAC6HDAC1HDAC4HDAC8 | |
| SCHEMBL10555561 | 0.78 | S1PR1 (0.41) | HDAC6HDAC1HDAC5HDAC4HDAC8 | |
| SCHEMBL21223573 | 0.78 | HDAC4 (0.42) | HDAC6HDAC1HDAC5HDAC4HDAC8 | |
| SCHEMBL19071237 | 0.77 | HDAC6 (0.72) | HDAC6HDAC1HDAC4HDAC8 | |
| SCHEMBL21223168 | 0.76 | HDAC6 (0.43) | HDAC6HDAC1HDAC5HDAC4HDAC8 | |
| SCHEMBL21223404 | 0.76 | HDAC6 (0.41) | HDAC6HDAC1HDAC5HDAC4HDAC8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220169621-A1 | OXADIAZOLES FOR USE IN CONTROLLING PHYTOPATHOGENIC FUNGI | PI INDUSTRIES LTD. (IN) | 2022-06-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220169621-A1 | OXADIAZOLES FOR USE IN CONTROLLING PHYTOPATHOGENIC FUNGI | OXA1L, CYP51A1, CYP1A1 | HDAC6 1374/4885HDAC1 725/4885HDAC5 1721/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.